Загрузка...
Efficacy of raltegravir, etravirine and darunavir/ritonavir for treatment-experienced HIV patients from a non-urban clinic population in the United States
BACKGROUND: The regimen of raltegravir (RAL), ritonavir-boosted darunavir (DAR/r), and etravirine (ETR) for HIV treatment-experienced patients in a non-clinical trial setting in the rural/semi-urban United States had not been evaluated. OBJECTIVE: A retrospective cohort analysis was performed of adu...
Сохранить в:
| Опубликовано в: : | Ther Adv Infect Dis |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5593223/ https://ncbi.nlm.nih.gov/pubmed/28959444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2049936117718101 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|